Daxor Corp
Research Daxor Corp (DXR) on Bullrun: market cap USD 60.66M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDXR
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyUSD
- Market capUSD 60.66M
- Financial periodQ2 2026
Valuation Snapshot
latest market cap is USD 60.66M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 10.30M | USD 9.17M | USD 570.94K | n/a | 1.64 | n/a | USD 262.93K | USD 45.89M |
| FY2024 | USD 2.13M | USD 536.33K | USD 25.69K | n/a | -0.09 | n/a | USD 729.97K | USD 35.79M |
| FY2023 | USD 1.28M | USD 280.64K | -USD 3.66M | n/a | 0.14 | n/a | USD 755.66K | USD 34.01M |
| FY2022 | USD 6.31M | USD 5.18M | -USD 769.30K | n/a | 1.09 | n/a | USD 1.23M | USD 28.97M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 60.66M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 74.63M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 37.94M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 46.01M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 39.05M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 45.60M | n/a | n/a | n/a |
About Daxor Corp
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Daxor Corp's market cap?
Daxor Corp's market capitalization is USD 60.66M.
What does Daxor Corp do?
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation operates as a subsidiary of Estate Of Joseph Feldschuh.